Fluidigm's Shares Continue Strong 2015 Start, Pacing February Gainers in Omics/MDx Space | GenomeWeb

NEW YORK (GenomeWeb) – Fluidigm continued its strong start to 2015 as its shares rose almost 15 percent month over month in February, pacing the gainers in the GenomeWeb Index for the month. 

Overall, the index of 31 firms in the omics life science tools and molecular diagnostics space was up 3 percent month over month. It trailed the Dow Jones Industrial Average, which was up 6 percent last month, the Nasdaq, which improved 7 percent, and the Nasdaq Biotech Index, which increased 5 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.